Cargando…

Epigenetic Drivers in Pediatric Medulloblastoma

Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regula...

Descripción completa

Detalles Bibliográficos
Autores principales: Roussel, Martine F., Stripay, Jennifer L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807456/
https://www.ncbi.nlm.nih.gov/pubmed/29178021
http://dx.doi.org/10.1007/s12311-017-0899-9
_version_ 1783299270424657920
author Roussel, Martine F.
Stripay, Jennifer L.
author_facet Roussel, Martine F.
Stripay, Jennifer L.
author_sort Roussel, Martine F.
collection PubMed
description Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regulate the chromatin and access of transcription factors to DNA and in turn gene transcription. Alteration of chromatin is now recognized to be deregulated in many cancers. Medulloblastoma is an embryonal tumor of the cerebellum and the most common malignant brain tumor in children, that occurs only rarely in adults. Medulloblastoma is characterized by four major molecularly and histopathologically distinct groups, wingless (WNT), sonic hedgehog (SHH), group 3 (G3), and group 4 (G4), that, except for WNT, are each now subdivided in several subgroups. Gene expression array, next-generation sequencing, and methylation profiling of several hundred primary tumors by several consortia and independent groups revealed that medulloblastomas harbor a paucity of mutations most of which occur in epigenetic regulators, genetic alterations in oncogenes and tumor suppressors, in addition to copy number alterations and chromosome gains and losses. Remarkably, some tumors have no reported mutations, suggesting that some genes required for oncogenesis might be regulated by epigenetic mechanisms which are still to be uncovered and validated. This review will highlight several epigenetic regulators focusing mainly on histone modifiers identified in medulloblastoma.
format Online
Article
Text
id pubmed-5807456
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-58074562018-02-13 Epigenetic Drivers in Pediatric Medulloblastoma Roussel, Martine F. Stripay, Jennifer L. Cerebellum Review Epigenetics is the process by which gene expression is regulated by events other than alterations of the genome. This includes DNA methylation, histone modifications, chromatin remodeling, microRNAs, and long non-coding RNAs. Methylation of DNA, chromatin remodeling, and histone modifications regulate the chromatin and access of transcription factors to DNA and in turn gene transcription. Alteration of chromatin is now recognized to be deregulated in many cancers. Medulloblastoma is an embryonal tumor of the cerebellum and the most common malignant brain tumor in children, that occurs only rarely in adults. Medulloblastoma is characterized by four major molecularly and histopathologically distinct groups, wingless (WNT), sonic hedgehog (SHH), group 3 (G3), and group 4 (G4), that, except for WNT, are each now subdivided in several subgroups. Gene expression array, next-generation sequencing, and methylation profiling of several hundred primary tumors by several consortia and independent groups revealed that medulloblastomas harbor a paucity of mutations most of which occur in epigenetic regulators, genetic alterations in oncogenes and tumor suppressors, in addition to copy number alterations and chromosome gains and losses. Remarkably, some tumors have no reported mutations, suggesting that some genes required for oncogenesis might be regulated by epigenetic mechanisms which are still to be uncovered and validated. This review will highlight several epigenetic regulators focusing mainly on histone modifiers identified in medulloblastoma. Springer US 2017-11-25 2018 /pmc/articles/PMC5807456/ /pubmed/29178021 http://dx.doi.org/10.1007/s12311-017-0899-9 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Roussel, Martine F.
Stripay, Jennifer L.
Epigenetic Drivers in Pediatric Medulloblastoma
title Epigenetic Drivers in Pediatric Medulloblastoma
title_full Epigenetic Drivers in Pediatric Medulloblastoma
title_fullStr Epigenetic Drivers in Pediatric Medulloblastoma
title_full_unstemmed Epigenetic Drivers in Pediatric Medulloblastoma
title_short Epigenetic Drivers in Pediatric Medulloblastoma
title_sort epigenetic drivers in pediatric medulloblastoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5807456/
https://www.ncbi.nlm.nih.gov/pubmed/29178021
http://dx.doi.org/10.1007/s12311-017-0899-9
work_keys_str_mv AT rousselmartinef epigeneticdriversinpediatricmedulloblastoma
AT stripayjenniferl epigeneticdriversinpediatricmedulloblastoma